Biggest News Aggregation in the World
📰 Linkedin News

Page 358 - Linkedin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Telix Pharmaceuticals Limited: Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer

CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer.Establishes proof-of-concept for Telix's proprietary
United States Davidn Cade Kyahn Williamson Telix Pharmaceuticals Limited Corporate Communications Telix Pharmaceuticals Limited Disclosure Committee

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science